Prognostic factors in patients with metastatic urothelial carcinoma who have been treated with atezolizumab


Tural D., Olmez O. F. , Sumbul A. T. , Ozhan N., Akar E., Cakar B., ...Daha Fazla

ESMO Virtual Congress, ELECTR NETWORK, 19 Eylül - 18 Ekim 2020, cilt.31 identifier